Actively Recruiting
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
Led by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Updated on 2024-10-18
180
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study was an open-label phase I study to evaluate the safety, tolerability, PK profile and potential efficacy of SSGJ-705 as a single agent in patients with advanced malignancies.
CONDITIONS
Official Title
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females aged over 18 years
- Histologically or cytologically confirmed locally advanced, recurrent, or metastatic malignancies
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Expected survival time greater than 3 months
- Signed informed consent form
- Adequate organ function
You will not qualify if you...
- Any adverse events greater than grade 1 from prior anti-tumor treatments, except hair loss, fatigue, and grade 2 peripheral neurotoxicity
- Pregnant or nursing women or men and women planning to have children
- Symptomatic metastasis in the central nervous system
- Allergic reactions to antibody drugs or any components of the study drug
- Severe difficulty breathing at rest due to cancer complications or need for supplemental oxygen
- Participation in another clinical study involving medical devices or drugs within one month prior to screening, except non-intervention or follow-up studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affiliated Cancer Hospital of Shandong First Medical University
Jinan, Shandong, China
Actively Recruiting
Research Team
J
Jinming Yu, MD,Ph.D
CONTACT
Y
Yuping Sun, MD,Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here